Hau Bosun 4
4 · Cellular Biomedicine Group, Inc. · Filed Mar 13, 2018
Insider Transaction Report
Form 4
Hau Bosun
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy) (2014 Plan)
2018-02-06+285→ 285 totalExercise: $19.35From: 2018-04-27Exp: 2028-02-06→ Common Stock (285 underlying)